Yousif Capital Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.36M Sell
41,177
-483
-1% -$16K 0.01% 955
2025
Q1
$1.67M Sell
41,660
-1,126
-3% -$45.3K 0.02% 821
2024
Q4
$2.01M Sell
42,786
-1,487
-3% -$69.9K 0.02% 751
2024
Q3
$2.34M Sell
44,273
-4,823
-10% -$255K 0.03% 685
2024
Q2
$2.66M Buy
49,096
+3,663
+8% +$198K 0.03% 594
2024
Q1
$3.19M Sell
45,433
-3,496
-7% -$245K 0.04% 552
2023
Q4
$4.09M Sell
48,929
-1,494
-3% -$125K 0.05% 403
2023
Q3
$1.49M Sell
50,423
-2,877
-5% -$84.8K 0.02% 908
2023
Q2
$1.74M Sell
53,300
-2,588
-5% -$84.4K 0.02% 851
2023
Q1
$1.97M Sell
55,888
-6,950
-11% -$245K 0.03% 785
2022
Q4
$2.88M Sell
62,838
-13,145
-17% -$602K 0.04% 550
2022
Q3
$3.68M Buy
75,983
+5,718
+8% +$277K 0.05% 381
2022
Q2
$2.76M Sell
70,265
-4,985
-7% -$196K 0.04% 582
2022
Q1
$2.77M Buy
75,250
+905
+1% +$33.3K 0.03% 712
2021
Q4
$3.39M Buy
+74,345
New +$3.39M 0.04% 600